Back
Akari Therapeutics PLC 10K Form
Buy
53
AKTX
Akari Therapeutics PLC
Last Price:
3.10
Seasonality Move:
-9.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2016-05-12 | 10Q | AKTX/Akari Therapeutics PLC Quarterly |
| 2016-03-23 | 10K | AKTX/Akari Therapeutics PLC Annual |
| 2015-11-23 | 10Q | AKTX/Akari Therapeutics PLC Quarterly |
| 2015-08-12 | 10Q | AKTX/Akari Therapeutics PLC Quarterly |
| 2015-05-12 | 10Q | AKTX/Akari Therapeutics PLC Quarterly |
| 2015-02-11 | 10K | AKTX/Akari Therapeutics PLC Annual |
Receive AKTX News And Ratings
See the #1 stock for the next 7 days that we like better than AKTX
AKTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.89M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.30 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.15650 |
|---|---|
| Net Income (TTM): | $-16.12M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Akari Therapeutics PLC Earnings Forecast
Key Akari Therapeutics PLC Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 14 years have been positive in 7 years.
Akari Therapeutics PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AKTX |
| CUSIP: | 00972G |
| Website: | akaritx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AKTX Technical Analysis vs Fundamental Analysis
Buy
53
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Buy
The current Akari Therapeutics PLC [AKTX] share price is $3.14. The Score for AKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.